Trump pushes FDA to quickly clear coronavirus antibody treatments, erroneously calling them a ‘cure’

By inserting himself again into the process of greenlighting treatments — as he did with hydroxychloroquine and convalescent plasma — Trump risks further undermining trust in regulators and confusing Americans, critics say, noting that his own hopeful story may not reflect how the drug works…

Continue Reading

You might also like